Rapid learning in practice: A lung cancer survival decision support system in routine patient care data

Radiotherapy and Oncology

Volumn 113, Issue 1, 2014, Pages 47-53

  Dekker, Andre ^a,b,c   Vinod, Shalini ^a,d,e   Holloway, Lois ^a,c,d,f   Oberije, Cary ^b   George, Armia ^a   Goozee, Gary ^a,d   Delaney, Geoff P ^a,d,e   Lambin, Philippe ^b   Thwaites, David ^c  

^a INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF WESTERN SYDNEY   (Australia)

^f UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

Decision support system; Lung cancer; Radiotherapy; Rapid learning

Indexed keywords

AGED; ARTICLE; CANCER CENTER; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEARNING ENVIRONMENT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIOTHERAPY PLANNING SYSTEM; SURVIVAL RATE; AUSTRALIA; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; EPIDEMIOLOGY; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MORTALITY; MULTICENTER STUDY; NETHERLANDS; PATHOLOGY; PROCEDURES; PROFESSIONAL PRACTICE; PROGNOSIS; VALIDATION STUDY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; NETHERLANDS; NEW SOUTH WALES; PATIENT CARE; PROFESSIONAL PRACTICE; PROGNOSIS;

EID: 84922638163     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.08.013     Document Type: Article

References (23)

1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62: 220-41.
3. Smith SL, Palma D, Parhar T, Alexander CS, Wai ES. Inoperable early stage nonsmall cell lung cancer: comorbidity, patterns of care and survival. Lung Cancer 2011; 72: 39-44.
4. O'Rourke N, Macbeth F. Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? A review of guidelines and evidence. Clin Oncol 2010; 22: 347-55.
5. De Ruysscher D, van Baardwijk A, Steevens J, Botterweck A, Bosmans G, Reymen B, et al. Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study. Radiother Oncol 2012; 102: 228-33.
6. Lambin P, van Stiphout RGPM, Starmans MHW, Rios-Velazquez E, Nalbantov G, Aerts HJWL, et al. Predicting outcomes in radiation oncology-multifactorial decision support systems. Nat Rev Clin Oncol 2013; 10: 27-40.
7. Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 2011; 12: 933-80.
8. Abernethy AP, Etheredge LM, Ganz PA, Wallace P, German RR, Neti C, et al. Rapid-learning system for cancer care. J Clin Oncol 2010; 28: 4268-74.
9. Dehing-Oberije C, Yu S, De Ruysscher D, Meersschout S, Van Beek K, Lievens Y, et al. Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 2009; 74: 355-62.
10. Warnock MJ, Toland C, Evans D, Wallace B, Nagy P. Benefits of using the DCM4CHE DICOM archive. J Digit Imaging 2007; 20: 125-9.
11. Pathak J, Kiefer RC, Chute CG. Using linked data for mining drug-drug interactions in electronic health records. Stud Health Technol Inform 2013; 192: 682-6.
12. Jayasurya K, Fung G, Yu S, Dehing-Oberije C, De Ruysscher D, Hope A, et al. Comparison of Bayesian network and support vector machine models for twoyear survival prediction in lung cancer patients treated with radiotherapy. Med Phys 2010; 37: 1401-7.
13. Bouwmeester W, Zuithoff NPA, Mallett S, Geerlings MI, Vergouwe Y, Steyerberg EW, et al. Reporting and methods in clinical prediction research: a systematic review. PLoS Med 2012; 9: e1001221.
14. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010; 21: 128-38.
15. Lambin P, Petit SF, Aerts HJWL, van Elmpt WJC, Oberije CJG, Starmans MHW, et al. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer. Radiother Oncol 2009; 2010: 145-52.
16. Grand MM, O'Brien PC. Obstacles to participation in randomised cancer clinical trials: a systematic review of the literature. J Med Imaging Radiat Oncol 2012; 56: 31-9.
17. Santanam L, Hurkmans C, Mutic S, van Vliet-Vroegindeweij C, Brame S, Straube W, et al. Standardizing naming conventions in radiation oncology. Int J Radiat Oncol Biol Phys 2012; 83: 1344-9.
18. Luta G, Ford MB, Bondy M, Shields PG, Stamey JD. Bayesian sensitivity analysis methods to evaluate bias due to misclassification and missing data using informative priors and external validation data. Cancer Epidemiol 2013; 37: 121-6.
19. Dehing-Oberije C, De Ruysscher D, van der Weide H, Hochstenbag M, Bootsma G, Geraedts W, et al. Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo) radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 1039-44.
20. Oberije C, Nalbantov G, Dekker A, Boersma L, Borger J, Reymen B, et al. A prospective study comparing the predictions of doctors versus models for treatment outcome of lung cancer patients: a step toward individualized care and shared decision making. Radiother Oncol J Eur Soc Ther Radiol Oncol 2014.
21. Van Baardwijk A, Bosmans G, Bentzen SM, Boersma L, Dekker A, Wanders R, et al. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial. Int J Radiat Oncol Biol Phys 2008; 71: 1103-10.
22. Oh JH, Craft J, Al Lozi R, Vaidya M, Meng Y, Deasy JO, et al. A Bayesian network approach for modeling local failure in lung cancer. Phys Med Biol 2011; 56: 1635-51.
23. Sledge G, Miller R, Hauser R. CancerLinQ and the future of cancer care. Am Soc Clin Oncol Educ Book 2012; 2013: 430-4.